Search

everythinglearnresearchcommunity

for

Search:↓

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Women who had cancer treatment feel both positive and negative about their bodies.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

A 50-year-old woman with breast cancer developed an autoimmune skin disorder, highlighting the need for thorough checks and team-based treatment.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

A new gel form of minoxidil is equally effective for hair growth and safer for the heart and other organs than the traditional solution.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Certain spices may help prevent and treat skin cancer, but more human trials are needed.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

CEC levels may be a useful marker for predicting prostate cancer progression.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Hair loss is a common side effect of hormone treatments for cancer.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Ginseng may help treat cancer and reduce treatment side effects, but more research is needed.